Similar articles for PMID: 16698330

Year	Number of Results
1956	6
1957	1
1958	9
1959	1
1960	5
1961	1
1962	4
1970	1
1974	1
1977	1
1993	1
1998	2
2000	1
2003	5
2004	5
2005	8
2006	12
2007	9
2008	13
2009	15
2010	1
2011	3
2012	2
2014	1
2024	0

1

Cardiovascular effects of aldosterone and post-acute myocardial infarction pathophysiology.

Cohn JN, Colucci W. Cohn JN, et al. Am J Cardiol. 2006 May 22;97(10A):4F-12F. doi: 10.1016/j.amjcard.2006.03.004. Epub 2006 Apr 5. Am J Cardiol. 2006. PMID: 16698330 Review.

2

Fiftieth anniversary of aldosterone: from discovery to cardiovascular therapy.

Tan LB, Schlosshan D, Barker D. Tan LB, et al. Int J Cardiol. 2004 Sep;96(3):321-33. doi: 10.1016/j.ijcard.2004.05.004. Int J Cardiol. 2004. PMID: 15310530 Review.

3

Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.

Duprez DA. Duprez DA. J Hypertens. 2006 Jun;24(6):983-91. doi: 10.1097/01.hjh.0000226182.60321.69. J Hypertens. 2006. PMID: 16685192 Review.

4

Brain renin-angiotensin-aldosterone system and ventricular remodeling after myocardial infarct: a review.

Westcott KV, Huang BS, Leenen FH. Westcott KV, et al. Can J Physiol Pharmacol. 2009 Dec;87(12):979-88. doi: 10.1139/Y09-067. Can J Physiol Pharmacol. 2009. PMID: 20029534 Review.

5

Aldosterone receptor antagonism in heart failure.

Jennings DL, Kalus JS, O'Dell KM. Jennings DL, et al. Pharmacotherapy. 2005 Aug;25(8):1126-33. doi: 10.1592/phco.2005.25.8.1126. Pharmacotherapy. 2005. PMID: 16207104 Review.

6

Measuring and targeting aldosterone and renin in atherosclerosis-a review of clinical data.

Hillaert MA, Lentjes EG, Beygui F, Kemperman H, Asselbergs FW, Nathoe HM, Agostoni P, Voskuil M, Ivanes F, Jude B, Bertrand ME, Pasterkamp G, van der Graaf Y, Doevendans PA, Montalescot G, Van Belle E. Hillaert MA, et al. Am Heart J. 2011 Oct;162(4):585-96. doi: 10.1016/j.ahj.2011.06.015. Epub 2011 Sep 9. Am Heart J. 2011. PMID: 21982648 Review.

7

Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction.

Huang BS, White RA, Ahmad M, Tan J, Jeng AY, Leenen FH. Huang BS, et al. Cardiovasc Res. 2009 Feb 15;81(3):574-81. doi: 10.1093/cvr/cvn222. Epub 2008 Aug 8. Cardiovasc Res. 2009. PMID: 18689429

8

[Aldosterone as an endogenous cardiovascular toxin and the options for its therapeutic management].

Horký K. Horký K. Vnitr Lek. 2011 Dec;57(12):1012-6. Vnitr Lek. 2011. PMID: 22277034 Review. Czech.

9

[Left ventricular remodeling post myocardial infarction].

Tsutamoto T, Horie M, Hayashi M. Tsutamoto T, et al. Nihon Rinsho. 2005 Mar;63 Suppl 3:323-9. Nihon Rinsho. 2005. PMID: 15813089 Review. Japanese. No abstract available.

10

Potential antiapoptotic activity of aldosterone antagonists in postinfarction remodeling.

Biondi-Zoccai GG, Abbate A, Baldi A. Biondi-Zoccai GG, et al. Circulation. 2003 Jul 29;108(4):e26. doi: 10.1161/01.CIR.0000081442.99984.EF. Circulation. 2003. PMID: 12885738 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

103 results

Results by year